Clopidogrel recalls

The FDA has published 4 recalls involving Clopidogrel since 2018. The latest was reported on 12 Apr 2023. Most were for manufacturing (cgmp) deviations. International Laboratories has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls4since 2018

Last 12 months0reported

Class I125% of total

Ongoing1latest 12 Apr 2023

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 25%Class II 3 75%Class III 0 0%

Why clopidogrel is recalled

Companies

By year

2023250%
2021125%
2018125%

Ongoing clopidogrel recalls

1 active

Reported	Class	Recall	Company	Reason	Where
12 Apr 2023Drug	CLASS II	Clopidogrel Tablets USP, 75 mg recalled by Preferred Pharmaceuticals	Preferred Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide

All clopidogrel recalls, newest first

4 total

Reported	Class	Recall	Company	Reason	Where
12 Apr 2023Drug	CLASS II	Clopidogrel Tablets USP, 75 mg recalled by Preferred Pharmaceuticals	Preferred Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
8 Mar 2023Drug	CLASS II	Clopidogrel Tablets USP, 75 mg recalled by Accord Healthcare	Accord Healthcare	Manufacturing (CGMP) Deviations	PR
8 Sep 2021Drug	CLASS II	Clopidogrel Tablets, USP, 75 mg recalled by Macleods Pharma UsaClopidogrel	Macleods Pharma Usa	Foreign Material	Nationwide
7 Feb 2018Drug	CLASS I	Clopidogrel Tablets, USP 75 mg recalled by International Laboratories	International Laboratories	Packaging Defects	Nationwide

Should you stop taking Clopidogrel?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.